Cathy Tie Launches Origin Genomics to Advance Responsible Germline Gene Correction in the United States

AI Briefing

• – Cathy Tie launches Origin Genomics to advance germline gene correction for severe inherited diseases, builds on previous work at Manhattan Genomics
• – Company will operate exclusively in the US, with a focus on responsible genomic medicine
• – Origin Genomics aims to make significant strides in precision germline gene correction for rare genetic disorders